Hyloris Ramps Up Product Expansion With New Idiopathic Rhinitis Spray

Hyloris Plans Four New Candidate Product Additions On Average Per Year From 2022

Blue-tone 3-D graphic of the side of a human head revealing nasal cavities lit up in orange
Hyloris announces they are developing an intranasal spray for hard-to-treat idiopathic rhinitis • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Value Added Medicines

More from Products